Were the Nexxen (NEXN) CFO’s share sales under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected pursuant to a Rule 10b5-1 trading plan . That plan was adopted on August 19, 2025 , indicating the transactions were pre-arranged rather than discretionary trades timed after later information became available.

Nexxen International (NEXN) CFO sells 106,345 shares in Rule 10b5-1 plan trades

Q: What insider activity did Nexxen International (NEXN) report in this Form 4?

Nexxen International reported that its CFO, Niri Sagi , executed open-market sales of 106,345 common shares . The sales took place over four transactions on July 13 and July 15, 2026, at per-share prices of $9.9585 and $10.1585 .

Q: How many Nexxen (NEXN) shares did the CFO sell and at what prices?

The CFO sold a total of 106,345 common shares of Nexxen International. The transactions were executed at share prices of $9.9585 and $10.1585 , according to the reported non-derivative open-market sale transactions on July 13 and 15, 2026.

Q: What type of transactions did Nexxen (NEXN) report for its CFO?

All reported transactions were non-derivative open-market sales of common stock, coded as “S” . There were four separate sale entries and no derivative exercises, gifts, or tax-withholding dispositions reported in this disclosure for the chief financial officer.

Q: Did the Nexxen (NEXN) CFO acquire or exercise any derivatives in this filing?

No. The disclosure shows no derivative transactions , with the derivative transaction count and exercise shares both at zero . The only reported activity consists of non-derivative open-market sales of Nexxen International common stock by the chief financial officer.

Q: How many insider sale transactions did Nexxen (NEXN) disclose for its CFO?

The transaction summary shows four sale transactions and no purchases . All four are classified as non-derivative open-market or private sale transactions in Nexxen International common stock, resulting in a net-sell position of 106,345 shares for this reporting period.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Nexxen International Ltd.’s chief financial officer, Niri Sagi, reported open-market sales of 106,345 shares of common stock. The transactions occurred on July 13 and July 15, 2026, at prices of $9.9585 and $10.1585 per share. According to a footnote, these sales were effected under a pre-arranged Rule 10b5-1 trading plan adopted on August 19, 2025.

Insights

Analyzing...

Insider Trade Summary 10b5-1

Net Seller: 106,345 shares ($1,065,937)

Net Sell 4 txns

Insider Niri Sagi

Role Chief Financial Officer

Sold 106,345 shs ($1.07M)

Type	Security	Shares	Price	Value
Sale	Common Stock	14,668	$10.1585	$149K
Sale	Common Stock	17,421	$10.1585	$177K
Sale	Common Stock	2,411	$10.1585	$24K
Sale	Common Stock	71,845	$9.9585	$715K

Holdings After Transaction: Common Stock — 198,898 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Total shares sold: 106,345 shares Sale price per share (July 15, 2026 trades): $10.1585 per share Sale price per share (July 13, 2026 trade): $9.9585 per share +3 more

6 metrics

Total shares sold 106,345 shares Aggregate non-derivative open-market sales reported for CFO Niri Sagi

Sale price per share (July 15, 2026 trades) $10.1585 per share Price for three non-derivative common stock sale entries on 2026-07-15

Sale price per share (July 13, 2026 trade) $9.9585 per share Price for one non-derivative common stock sale entry on 2026-07-13

Number of sale transactions 4 SellCount in transaction summary for this reporting period

Net buy/sell direction net-sell of 106,345 shares Transaction summary netBuySellDirection and netBuySellShares

Rule 10b5-1 plan adoption date August 19, 2025 Date the reporting person adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, open-market sale, non-derivative, net-sell

4 terms

Rule 10b5-1 trading plan regulatory

"The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"Transaction action is described as an open-market sale of common stock."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

non-derivative financial

"Each reported common stock transaction is classified as non-derivative."

net-sell financial

"The transaction summary shows a net-sell direction of 106,345 shares."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:46 PM Accepted by SEC EDGAR 07/16/2026 - 04:46 PM

FAQ

What insider activity did Nexxen International (NEXN) report in this Form 4?

Nexxen International reported that its CFO, Niri Sagi, executed open-market sales of 106,345 common shares. The sales took place over four transactions on July 13 and July 15, 2026, at per-share prices of $9.9585 and $10.1585.

How many Nexxen (NEXN) shares did the CFO sell and at what prices?

The CFO sold a total of 106,345 common shares of Nexxen International. The transactions were executed at share prices of $9.9585 and $10.1585, according to the reported non-derivative open-market sale transactions on July 13 and 15, 2026.

What type of transactions did Nexxen (NEXN) report for its CFO?

All reported transactions were non-derivative open-market sales of common stock, coded as “S”. There were four separate sale entries and no derivative exercises, gifts, or tax-withholding dispositions reported in this disclosure for the chief financial officer.

Did the Nexxen (NEXN) CFO acquire or exercise any derivatives in this filing?

No. The disclosure shows no derivative transactions, with the derivative transaction count and exercise shares both at zero. The only reported activity consists of non-derivative open-market sales of Nexxen International common stock by the chief financial officer.

How many insider sale transactions did Nexxen (NEXN) disclose for its CFO?

The transaction summary shows four sale transactions and no purchases. All four are classified as non-derivative open-market or private sale transactions in Nexxen International common stock, resulting in a net-sell position of 106,345 shares for this reporting period.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Niri Sagi

(Last)

(First)

(Middle)

82 YIGAL ALON STREET

(Street)

TEL AVIV

6789124

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nexxen International Ltd. [ NEXN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/13/2026		S⁽¹⁾		71,845	D	$9.9585	213,566	D
Common Stock	07/15/2026		S⁽¹⁾		14,668	D	$10.1585	198,898	D
Common Stock	07/15/2026		S⁽¹⁾		17,421	D	$10.1585	181,477	D
Common Stock	07/15/2026		S⁽¹⁾		2,411	D	$10.1585	179,066	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025.

	/s/ Shai Shulman	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR